Uncovering the Therapeutic Target and Molecular Mechanism of Upadacitinib on Sjogren's Syndrome
{{output}}
Objective: Upadacitinib, a selective Janus associated kinase 1 (JAK-1) inhibitor, can be prescribed particularly for the clinical treatment with Crohn's disease or rheumatoid arthritis. It is clinically observed that upadacitinib... ...
